John B. Sanfilippo & Son Financials
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
John B. Sanfilippo & Son has an operating margin of 7.6%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 38/100, indicating healthy but not exceptional operating efficiency. This is down from 8.0% the prior year.
John B. Sanfilippo & Son's revenue grew a modest 3.8% year-over-year to $1.1B. This slow but positive growth earns a score of 39/100.
John B. Sanfilippo & Son carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 2.22, John B. Sanfilippo & Son holds $2.22 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 69/100.
While John B. Sanfilippo & Son generated $30.5M in operating cash flow, capex of $50.7M consumed most of it, leaving -$20.2M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
John B. Sanfilippo & Son earns a strong 16.3% return on equity (ROE), meaning it generates $16 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 65/100. This is down from 18.7% the prior year.
John B. Sanfilippo & Son scores 5.59, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
John B. Sanfilippo & Son passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, John B. Sanfilippo & Son generates $0.52 in operating cash flow ($30.5M OCF vs $58.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
John B. Sanfilippo & Son earns $23.8 in operating income for every $1 of interest expense ($84.7M vs $3.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
This page shows John B. Sanfilippo & Son (JBSS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
John B. Sanfilippo & Son generated $1.1B in revenue in fiscal year 2025. This represents an increase of 3.8% from the prior year.
John B. Sanfilippo & Son's EBITDA was $111.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 1.7% from the prior year.
John B. Sanfilippo & Son generated -$20.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 127.5% from the prior year.
John B. Sanfilippo & Son reported $58.9M in net income in fiscal year 2025. This represents a decrease of 2.2% from the prior year.
John B. Sanfilippo & Son earned $5.03 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 2.3% from the prior year.
John B. Sanfilippo & Son held $585K in cash against $14.6M in long-term debt as of fiscal year 2025.
John B. Sanfilippo & Son paid $2.10 per share in dividends in fiscal year 2025. This represents a decrease of 30.0% from the prior year.
John B. Sanfilippo & Son's gross margin was 18.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the prior year.
John B. Sanfilippo & Son's operating margin was 7.6% in fiscal year 2025, reflecting core business profitability. This is down 0.3 percentage points from the prior year.
John B. Sanfilippo & Son's net profit margin was 5.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.3 percentage points from the prior year.
John B. Sanfilippo & Son's ROE was 16.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.3 percentage points from the prior year.
John B. Sanfilippo & Son invested $3.5M in research and development in fiscal year 2025. This represents a decrease of 3.5% from the prior year.
John B. Sanfilippo & Son invested $50.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 79.1% from the prior year.
JBSS Income Statement
| Metric | Q2'25 | Q1'25 | Q3'25 | Q2'24 | Q1'24 | Q3'24 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $314.8M+5.4% | $298.7M+14.5% | $260.9M-13.3% | $301.1M+9.0% | $276.2M+1.6% | $271.9M-6.6% | $291.2M+24.4% | $234.1M |
| Cost of Revenue | $255.6M+4.5% | $244.6M+19.3% | $205.0M-17.6% | $248.8M+8.3% | $229.7M+3.1% | $222.7M-4.5% | $233.3M+31.7% | $177.1M |
| Gross Profit | $59.2M+9.4% | $54.1M-3.2% | $55.9M+7.0% | $52.3M+12.3% | $46.5M-5.4% | $49.2M-15.1% | $57.9M+1.6% | $57.0M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $12.1M+31.0% | $9.2M+1.4% | $9.1M-11.7% | $10.3M+5.8% | $9.7M-20.3% | $12.2M+5.3% | $11.6M+10.6% | $10.5M |
| Operating Income | $26.0M-3.9% | $27.0M-4.2% | $28.2M+45.6% | $19.4M+13.9% | $17.0M-7.3% | $18.4M-33.5% | $27.6M+12.3% | $24.6M |
| Interest Expense | $503K-48.9% | $984K-6.7% | $1.1M+36.7% | $772K+49.6% | $516K-34.3% | $785K-25.6% | $1.1M+364.8% | $227K |
| Income Tax | $6.6M+3.3% | $6.3M+5.9% | $6.0M+39.5% | $4.3M+5.8% | $4.1M+18.9% | $3.4M-49.5% | $6.8M+11.7% | $6.1M |
| Net Income | $18.0M-4.1% | $18.7M-7.1% | $20.2M+48.2% | $13.6M+16.6% | $11.7M-13.5% | $13.5M-29.7% | $19.2M+9.0% | $17.6M |
| EPS (Diluted) | $1.53-3.8% | $1.59-7.6% | $1.72+48.3% | $1.16+16.0% | $1.00-13.0% | $1.15-29.9% | $1.64+8.6% | $1.51 |
JBSS Balance Sheet
| Metric | Q2'25 | Q1'25 | Q3'25 | Q2'24 | Q1'24 | Q3'24 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $617.7M+3.2% | $598.7M+1.5% | $590.0M+8.2% | $545.3M+5.0% | $519.4M+5.6% | $491.9M+1.5% | $484.5M+14.0% | $424.9M |
| Current Assets | $337.2M+1.1% | $333.5M-4.5% | $349.2M+13.9% | $306.7M+6.7% | $287.5M-3.0% | $296.3M+2.3% | $289.8M+15.2% | $251.6M |
| Cash & Equivalents | $2.4M+236.1% | $714K-44.9% | $1.3M+285.4% | $336K-24.0% | $442K+17.2% | $377K-80.9% | $2.0M+135.7% | $838K |
| Inventory | $235.4M+0.3% | $234.7M-9.0% | $257.8M+25.2% | $205.8M+5.8% | $194.6M-7.6% | $210.7M+6.8% | $197.3M+12.9% | $174.8M |
| Accounts Receivable | $79.8M-5.4% | $84.4M+13.2% | $74.5M-8.2% | $81.2M-3.1% | $83.8M+10.8% | $75.6M-2.3% | $77.4M+13.2% | $68.4M |
| Goodwill | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M |
| Total Liabilities | $247.6M+5.0% | $235.9M-3.1% | $243.4M+10.8% | $219.6M+5.3% | $208.6M+22.6% | $170.1M-4.0% | $177.2M+28.9% | $137.5M |
| Current Liabilities | $148.4M+8.6% | $136.7M-21.5% | $174.0M+15.9% | $150.1M+7.3% | $139.8M+16.2% | $120.4M-6.2% | $128.3M+43.7% | $89.3M |
| Long-Term Debt | $28.8M-3.3% | $29.8M+417.4% | $5.8M-3.4% | $6.0M-3.2% | $6.2M-5.9% | $6.6M-2.8% | $6.7M-2.6% | $6.9M |
| Total Equity | $370.1M+2.0% | $362.8M+4.7% | $346.6M+6.4% | $325.6M+4.8% | $310.8M-3.4% | $321.8M+4.7% | $307.2M+6.9% | $287.4M |
| Retained Earnings | $229.0M+2.8% | $222.7M+7.1% | $208.0M+10.7% | $187.8M+7.8% | $174.2M-7.6% | $188.6M+7.7% | $175.1M+12.3% | $155.9M |
JBSS Cash Flow Statement
| Metric | Q2'25 | Q1'25 | Q3'25 | Q2'24 | Q1'24 | Q3'24 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $62.5M+94.5% | $32.1M+224.1% | -$25.9M-335.9% | $11.0M+22.9% | $8.9M+69.7% | $5.3M-86.6% | $39.3M+79.6% | $21.9M |
| Capital Expenditures | $22.4M-9.8% | $24.9M+113.0% | $11.7M-14.4% | $13.6M+14.7% | $11.9M+80.7% | $6.6M+34.7% | $4.9M-18.4% | $6.0M |
| Free Cash Flow | $40.0M+451.9% | $7.3M+119.3% | -$37.6M-1309.6% | -$2.7M+10.1% | -$3.0M-124.7% | -$1.3M-103.8% | $34.4M+116.5% | $15.9M |
| Investing Cash Flow | -$21.3M+14.5% | -$24.9M-112.7% | -$11.7M+14.2% | -$13.7M-14.3% | -$12.0M-81.5% | -$6.6M+89.7% | -$63.9M-956.3% | -$6.0M |
| Financing Cash Flow | -$39.5M-458.3% | -$7.1M-118.3% | $38.6M+1399.0% | $2.6M-13.6% | $3.0M+1171.9% | -$278K-101.1% | $25.7M+251.7% | -$16.9M |
| Dividends Paid | $0-100.0% | $17.5M | $0 | $0-100.0% | $24.4M | $0 | $0-100.0% | $23.2M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
JBSS Financial Ratios
| Metric | Q2'25 | Q1'25 | Q3'25 | Q2'24 | Q1'24 | Q3'24 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.8%+0.7pp | 18.1%-3.3pp | 21.4%+4.1pp | 17.4%+0.5pp | 16.9%-1.2pp | 18.1%-1.8pp | 19.9%-4.5pp | 24.4% |
| Operating Margin | 8.3%-0.8pp | 9.0%-1.8pp | 10.8%+4.4pp | 6.4%+0.3pp | 6.2%-0.6pp | 6.8%-2.7pp | 9.5%-1.0pp | 10.5% |
| Net Margin | 5.7%-0.6pp | 6.3%-1.4pp | 7.7%+3.2pp | 4.5%+0.3pp | 4.2%-0.7pp | 5.0%-1.6pp | 6.6%-0.9pp | 7.5% |
| Return on Equity | 4.9%-0.3pp | 5.2%-0.6pp | 5.8%+1.6pp | 4.2%+0.4pp | 3.8%-0.4pp | 4.2%-2.0pp | 6.2%+0.1pp | 6.1% |
| Return on Assets | 2.9%-0.2pp | 3.1%-0.3pp | 3.4%+0.9pp | 2.5%+0.2pp | 2.2%-0.5pp | 2.7%-1.2pp | 4.0%-0.2pp | 4.1% |
| Current Ratio | 2.27-0.2 | 2.44+0.4 | 2.01-0.0 | 2.04-0.0 | 2.06-0.4 | 2.46+0.2 | 2.26-0.6 | 2.82 |
| Debt-to-Equity | 0.080.0 | 0.08+0.1 | 0.020.0 | 0.020.0 | 0.020.0 | 0.020.0 | 0.020.0 | 0.02 |
| FCF Margin | 12.7%+10.3pp | 2.4%+16.8pp | -14.4%-13.5pp | -0.9%+0.2pp | -1.1%-0.6pp | -0.5%-12.3pp | 11.8%+5.0pp | 6.8% |
Similar Companies
Frequently Asked Questions
What is John B. Sanfilippo & Son's annual revenue?
John B. Sanfilippo & Son (JBSS) reported $1.1B in total revenue for fiscal year 2025. This represents a 3.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is John B. Sanfilippo & Son's revenue growing?
John B. Sanfilippo & Son (JBSS) revenue grew by 3.8% year-over-year, from $1.1B to $1.1B in fiscal year 2025.
Is John B. Sanfilippo & Son profitable?
Yes, John B. Sanfilippo & Son (JBSS) reported a net income of $58.9M in fiscal year 2025, with a net profit margin of 5.3%.
What is John B. Sanfilippo & Son's earnings per share (EPS)?
John B. Sanfilippo & Son (JBSS) reported diluted earnings per share of $5.03 for fiscal year 2025. This represents a -2.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is John B. Sanfilippo & Son's EBITDA?
John B. Sanfilippo & Son (JBSS) had EBITDA of $111.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does John B. Sanfilippo & Son have?
As of fiscal year 2025, John B. Sanfilippo & Son (JBSS) had $585K in cash and equivalents against $14.6M in long-term debt.
What is John B. Sanfilippo & Son's gross margin?
John B. Sanfilippo & Son (JBSS) had a gross margin of 18.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is John B. Sanfilippo & Son's operating margin?
John B. Sanfilippo & Son (JBSS) had an operating margin of 7.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is John B. Sanfilippo & Son's net profit margin?
John B. Sanfilippo & Son (JBSS) had a net profit margin of 5.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does John B. Sanfilippo & Son pay dividends?
Yes, John B. Sanfilippo & Son (JBSS) paid $2.10 per share in dividends during fiscal year 2025.
What is John B. Sanfilippo & Son's return on equity (ROE)?
John B. Sanfilippo & Son (JBSS) has a return on equity of 16.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is John B. Sanfilippo & Son's free cash flow?
John B. Sanfilippo & Son (JBSS) generated -$20.2M in free cash flow during fiscal year 2025. This represents a -127.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is John B. Sanfilippo & Son's operating cash flow?
John B. Sanfilippo & Son (JBSS) generated $30.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are John B. Sanfilippo & Son's total assets?
John B. Sanfilippo & Son (JBSS) had $597.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are John B. Sanfilippo & Son's capital expenditures?
John B. Sanfilippo & Son (JBSS) invested $50.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does John B. Sanfilippo & Son spend on research and development?
John B. Sanfilippo & Son (JBSS) invested $3.5M in research and development during fiscal year 2025.
What is John B. Sanfilippo & Son's current ratio?
John B. Sanfilippo & Son (JBSS) had a current ratio of 2.22 as of fiscal year 2025, which is generally considered healthy.
What is John B. Sanfilippo & Son's debt-to-equity ratio?
John B. Sanfilippo & Son (JBSS) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is John B. Sanfilippo & Son's return on assets (ROA)?
John B. Sanfilippo & Son (JBSS) had a return on assets of 9.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is John B. Sanfilippo & Son's Altman Z-Score?
John B. Sanfilippo & Son (JBSS) has an Altman Z-Score of 5.59, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is John B. Sanfilippo & Son's Piotroski F-Score?
John B. Sanfilippo & Son (JBSS) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are John B. Sanfilippo & Son's earnings high quality?
John B. Sanfilippo & Son (JBSS) has an earnings quality ratio of 0.52x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can John B. Sanfilippo & Son cover its interest payments?
John B. Sanfilippo & Son (JBSS) has an interest coverage ratio of 23.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is John B. Sanfilippo & Son?
John B. Sanfilippo & Son (JBSS) scores 52 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.